Share Twitter LinkedIn Facebook Email Rod A. Humerickhouse, M.D., PhD Group Project Leader, Oncology Development, AbbVie Discusses Venetoclax In Treatment Of MM At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Teclistamab FDA Approval Biweekly Dosing Multiple Myeloma [3 KOL Interviews] Multiple Myeloma 13 Mins Read